Pure Global

ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A. - COFEPRIS Registration 1672R2022 SSA

Access comprehensive regulatory information for ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A. (ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1672R2022 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on December 16, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
1672R2022 SSA
ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A.
COFEPRIS Analysis ID: 1672R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
VENTANA CONFIRM ANTI-CD79A (SP18) RABBIT MONOCLONAL PRIMARY ANTIBODY.
Trade Name (English)
VENTANA CONFIRM ANTI-CD79A (SP18) RABBIT MONOCLONAL PRIMARY ANTIBODY.
Registration Information
Analysis ID
1672R2022 SSA
Registration Date
December 16, 2022
Manufacturer / Fabricante
Name (English)
PRODUCTOS ROCHE, S.A. DE C.V.